| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.4M | -82.7% |
| R&D Expense | $531.6M | +4.5% |
| SG&A Expense | $239.8M | +75.4% |
| Operating Income | -$759.6M | -32.5% |
| Pre-tax Income | -$740.4M | -28.0% |
| Income Tax | $508K | -84.6% |
| Net Income | -$740.9M | -27.3% |
| EPS (Basic) | -$13.18 | -17.6% |
| EPS (Diluted) | -$13.18 | -17.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $235.3M | -43.0% |
| Short-term Investments | $848.6M | -21.3% |
| Accounts Receivable | $865K | — |
| Inventory | $3.0M | — |
| Current Assets | $1.11B | -26.5% |
| Total Assets | $1.20B | -24.3% |
| Current Liabilities | $159.4M | +11.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$570.6M | -46.8% |
| Capital Expenditures | $4.9M | -50.5% |
| Investing Cash Flow | $225.8M | +138.3% |
| Financing Cash Flow | $166.9M | -67.0% |
| Free Cash Flow | -$575.4M | -44.4% |
| Total Liabilities |
| $206.1M |
| +7.5% |
| Stockholders' Equity | $996.5M | -28.7% |